EX-99 2 slab-20240724q2earningsrel.htm EX-99 Document

Exhibit 99
image.jpg
Silicon Labs Reports Second Quarter 2024 Results
Wireless IoT leader delivers strong second-quarter growth
AUSTIN, Texas – July 24, 2024 – Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported financial results for the second quarter, which ended June 29, 2024.
“Silicon Labs delivered another quarter of strong sequential growth, driven by a combination of design wins ramping to production in several key growth areas, and end customers working down their excess inventory,” said Matt Johnson, President and Chief Executive Officer at Silicon Labs. “Looking forward, we expect revenue growth to continue in the third quarter as excess inventory is further reduced, design wins continue ramping, and bookings improve.”
Second Quarter Financial Highlights
Revenue was $145 million
Industrial & Commercial revenue for the quarter was $88 million
Home & Life revenue for the quarter was $57 million
Results on a GAAP basis:
GAAP gross margin was 53%
GAAP operating expenses were $125 million
GAAP operating loss was $48 million
GAAP diluted loss per share was $(2.56)
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:
Non-GAAP gross margin was 53%
Non-GAAP operating expenses were $102 million
Non-GAAP operating loss was $25 million
Non-GAAP diluted loss per share was $(0.56)
Business Highlights
Due to popular demand, Silicon Labs is expanding its fifth annual Works With Developers Conference this fall with live events in San Jose, Hyderabad, and Shanghai. Each event’s agenda is tailored to regional market needs and covers key IoT topics like Matter, Smart Cities, AI and Machine Learning, and Security.

Announced Silicon Labs’ new xG22E family of wireless SoCs, its first-ever family designed to operate within the ultra-low power envelope required for battery-free, energy harvesting applications. The new family consists of the BG22E, MG22E, and FG22E. As Silicon Labs’ most energy-efficient SoCs to date, all three SoCs will enable IoT device makers to build high-performance, Bluetooth Low Energy (LE), 802.15.4-based, or proprietary 2.4GHz. wireless devices for battery-optimized and battery-free devices that can harvest energy from external sources in their environments like indoor or outdoor ambient light, ambient radio waves, and kinetic motion.



Business Outlook
The company expects third-quarter revenue to be between $160 to $170 million. The company also estimates the following results:
On a GAAP basis:
GAAP gross margin to be between 54% to 56%
GAAP operating expenses of approximately $123 million to $125 million
GAAP diluted loss per share per share between $(0.95) to $(1.25)
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
Non-GAAP gross margin to be between 54% to 56%
Non-GAAP operating expenses of approximately $101 million to $103 million
Non-GAAP diluted loss per share between $(0.10) to $(0.30)
Earnings Webcast and Conference Call
Silicon Labs will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be available on Silicon Labs’ website (www.silabs.com) under Investor Relations. In addition, the company will post an audio recording of the event at investor.silabs.com and make a replay available through August 24, 2024.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions that transform industries, grow economies, and improve lives. silabs.com
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of COVID-19 on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; risks associated with any material weakness in our internal controls over financial reporting; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any



intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.
CONTACT: Thomas Haws, Investor Relations Manager, (512) 416-8500, investor.relations@silabs.com



Silicon Laboratories Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(Unaudited)
Three Months EndedSix Months Ended
June 29,
2024
July 1,
2023
June 29,
2024
July 1,
2023
Revenues$145,367 $244,866 $251,742 $491,653 
Cost of revenues68,784 101,091 120,090 194,018 
Gross profit76,583 143,775 131,652 297,635 
Operating expenses:
Research and development85,909 85,902 166,559 175,298 
Selling, general and administrative38,695 40,706 72,248 85,597 
Operating expenses124,604 126,608 238,807 260,895 
Operating income (loss)(48,021)17,167 (107,155)36,740 
Other income (expense):
Interest income and other, net2,790 7,780 5,522 12,616 
Interest expense(263)(1,596)(772)(3,252)
Income (loss) before income taxes(45,494)23,351 (102,405)46,104 
Provision for income taxes36,663 12,338 36,278 20,091 
Equity-method loss— (57)— (1,090)
Net income (loss)$(82,157)$10,956 $(138,683)$24,923 
Earnings (loss) per share:
Basic$(2.56)$0.35 $(4.33)$0.78 
Diluted$(2.56)$0.33 $(4.33)$0.75 
Weighted-average common shares outstanding:
Basic32,12431,61432,01831,786
Diluted32,12432,92632,01833,339



Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
 Three Months Ended
June 29, 2024
Non-GAAP Income Statement ItemsGAAP
Measure
GAAP
Percent of
Revenue
Stock
Compensation
Expense
Intangible Asset
Amortization
Termination CostsNon-GAAP
Measure
Non-GAAP
Percent of
Revenue
Revenues$145,367 
Gross profit76,583 52.7 %$412 $— $— $76,995 53.0 %
Research and development85,909 59.1 %10,217 6,061 902 68,729 47.3 %
Selling, general and administrative38,695 26.6 %5,215 19 106 33,355 22.9 %
Operating expenses124,604 85.7 %15,432 6,080 1,008 102,084 70.2 %
Operating income (loss)(48,021)(33.0 %)15,844 6,080 1,008 (25,089)(17.3 %)
Three Months Ended
June 29, 2024
Non-GAAP Loss Per ShareGAAP
Measure
Stock
Compensation
Expense*
Intangible
Asset
Amortization*
Termination
Costs*
Income
Tax
Adjustments
Non-
GAAP
Measure
Net income (loss)$(82,157)$15,844 $6,080 $1,008 $41,176 $(18,049)
Diluted shares outstanding32,12432,124
Diluted loss per share$(2.56)$(0.56)
*Represents pre-tax amounts



Unaudited Forward-Looking Statements Regarding Business Outlook
(In millions, except per share data)

Three Months Ended
September 28, 2024
Business Outlook
GAAP
Measure
Non-GAAP
Adjustments**
Non-GAAP
Measure
Gross margin
54% to 56%
— %
54% to 56%
Operating expenses
$123 to $125
$(22)
$101 to $103
Diluted loss per share
$(0.95) to $(1.25)
$0.85 to $0.95
$(0.10) to $(0.30)
**Non-GAAP adjustments include the following estimates: stock compensation expense of $16.8 million, intangible asset amortization of $5.4 million, and the application of a long-term non-GAAP tax rate of 20%.




Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
June 29,
2024
December 30,
2023
Assets
Current assets:
Cash and cash equivalents$240,834 $227,504 
Short-term investments98,336 211,720 
Accounts receivable, net41,212 29,295 
Inventories166,079 194,295 
Prepaid expenses and other current assets53,585 75,117 
Total current assets600,046 737,931 
Property and equipment, net139,397 145,890 
Goodwill376,389 376,389 
Other intangible assets, net47,374 59,533 
Other assets, net86,781 123,313 
Total assets$1,249,987 $1,443,056 
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$39,295 $57,498 
Revolving line of credit— 45,000 
Deferred revenue and returns liability3,323 2,117 
Other current liabilities57,495 58,955 
Total current liabilities100,113 163,570 
Other non-current liabilities56,845 70,804 
Total liabilities156,958 234,374 
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued — — 
Common stock – $0.0001 par value; 250,000 shares authorized; 32,289 and 31,897 shares issued and outstanding at June 29, 2024 and December 30, 2023, respectively
Additional paid-in capital39,232 16,973 
Retained earnings 1,054,048 1,192,731 
Accumulated other comprehensive loss(254)(1,025)
Total stockholders’ equity1,093,029 1,208,682 
Total liabilities and stockholders’ equity$1,249,987 $1,443,056 



Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Six Months Ended
June 29,
2024
July 1,
2023
Operating Activities
Net income (loss)$(138,683)$24,923 
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation of property and equipment13,152 12,441 
Amortization of other intangible assets12,160 12,904 
Amortization of debt issuance costs — 960 
Stock-based compensation expense29,455 31,377 
Equity-method loss— 1,090 
Deferred income taxes29,784 (6,403)
Changes in operating assets and liabilities:
Accounts receivable(11,918)(26,819)
Inventories28,123 (45,064)
Prepaid expenses and other assets20,723 32,963 
Accounts payable(19,341)(30,003)
Other current liabilities and income taxes(13,624)(26,220)
Deferred revenue and returns liability1,206 4,326 
Other non-current liabilities(6,703)(1,975)
Net cash used in operating activities(55,666)(15,500)
Investing Activities
Purchases of marketable securities(17,700)(81,427)
Sales of marketable securities34,538 339,555 
Maturities of marketable securities97,458 171,691 
Purchases of property and equipment(5,577)(13,462)
Proceeds from sale of equity investment12,382 — 
Purchases of other assets— (215)
Net cash provided by investing activities121,101 416,142 
Financing Activities
Proceeds from revolving line of credit— 80,000 
Payments on debt(45,000)(536,124)
Repurchases of common stock— (201,095)
Payment of taxes withheld for vested stock awards(15,213)(16,310)
Proceeds from the issuance of common stock8,108 7,785 
Net cash used in financing activities(52,105)(665,744)
Increase (decrease) in cash and cash equivalents13,330 (265,102)
Cash and cash equivalents at beginning of period227,504 499,915 
Cash and cash equivalents at end of period$240,834 $234,813